Dominari Holdings Inc. (NASDAQ:DOMH - Get Free Report) declared a dividend on Monday, February 10th, NASDAQ Dividends reports. Stockholders of record on Monday, February 24th will be given a dividend of 0.32 per share on Monday, March 3rd. The ex-dividend date of this dividend is Monday, February 24th.
Dominari Trading Down 16.0 %
Dominari stock traded down $1.58 during trading on Wednesday, hitting $8.32. 592,572 shares of the company were exchanged, compared to its average volume of 2,572,133. The business's 50 day moving average is $3.54 and its 200 day moving average is $2.37. Dominari has a 52 week low of $0.83 and a 52 week high of $13.58. The company has a market capitalization of $52.72 million, a P/E ratio of -2.15 and a beta of 1.25.
Dominari Company Profile
(
Get Free Report)
Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Recommended Stories
Before you consider Dominari, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dominari wasn't on the list.
While Dominari currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
